Logo
Whalesbook
HomeNewsCorporate NewsPremiumStocks
HomeNewsCorporate NewsPremiumStocks

Global Health Ltd

₹ 1,2251.19%
07 Jan 10:04 a.m. – close price
🔗medanta.org•BSE: 543654•NSE: MEDANTA
Market Cap₹ 32,925 Cr.
Current Price₹ 1,225
High / Low₹ 1,456
Stock P/E62.7
Book Value₹ 141
Dividend Yield0.04 %
ROCE19.6 %
ROE15.2 %
Face Value₹ 2.00
Sales₹ 3,424 Cr.
OPM22.9 %
Mar Cap₹ 32,925 Cr.

ABOUT

Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. The company has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.[1]

KEY POINTS

Hospital Count[1]Global Health operates 6 hospitals under the"Medanta"brand in Gurugram, Indore, Ranchi, Lucknow, Patna and Noida. Spanning an area of 5.6 million sq. ft., they have 3,435 installed beds as on Sep 30, 2025. They provide healthcare services in over 30 medical specialties and engage 2,000+ doctors led by highly experienced department heads.

Also present in buckets:
Aggressive Growth TriggersExcellent ResultsRevenue GuidanceAsset Base ExpansionCapacity Expansion And ProductsJv Partnerships AcquisitionsCredit Rating UpdatesRed Flags And Poor Performance

Peer Comparision

S.No.NameCurrent Price (Rs.)Price to EarningMarket Capitalization (Rs.Cr.)Dividend yield (%)Net Profit latest quarter (Rs.Cr.)YOY Quarterly profit growth (%)Sales latest quarter (Rs.Cr.)YOY Quarterly sales growth (%)Return on capital employed (%)Sales (Rs.Cr.)OPM (%)Profit after tax (Rs.Cr.)Profit after tax latest quarter (Rs.Cr.)Price to book valueReturn on assets (%)Debt to equity
1.Apollo Hospitals7417.4563.82106651.550.26494.0025.986303.5012.7816.6423264.7014.291671.90477.2011.757.770.88
2.Max Healthcare1038.3071.71101026.760.14491.3074.342135.4725.0714.887941.0926.561409.01491.3010.048.320.33
3.Fortis Health.945.0070.8071343.550.11328.8240.232331.4417.2511.968433.6222.031007.34304.117.586.670.34
4.Narayana Hrudaya1930.0046.4039441.640.23258.4929.641643.7920.2820.755961.0923.53850.33258.169.7512.220.58
5.Global Health1224.9562.6932925.480.04140.2022.61926.4339.3919.563423.8322.90525.11128.098.7111.830.07
6.Aster DM Health.623.2587.9732291.900.80121.3113.831197.2110.2010.684325.2318.61367.05110.247.122.440.46
7.Krishna Institu.628.1576.4525134.730.0072.00-37.45960.7023.5915.003401.6022.98328.6867.1811.128.321.40
–Median: 28 Co.479.8251.965172.160.033.2321.3333.2316.915.01257.9720.58105.729.836.157.790.34

Quarterly Results

Standalone figures in ₹ crores

Dec 2022Dec 2023Dec 2024Jun 2023Jun 2024Jun 2025Mar 2023Mar 2024Mar 2025Sep 2022Sep 2023Sep 2024Sep 2025
Sales
490565812551611882506724803494580665926
Expenses
394439611435479688400560608391452514734
Operating Profit
95126202115132195106164195103128150193
Other Income
1323192727432530-2413262439
Profit before tax
8012117511613019810414912687127144185
Tax %
26%28%25%26%26%23%22%26%26%25%25%27%24%
Net Profit
5987131869615281109936595104140
EPS in Rs
2.193.254.893.213.595.653.024.083.482.583.543.895.22

Profit & Loss

Standalone Figures in ₹ Crores / Yearly

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales
1,2771,3431,4411,4721,2271,7651,9742,9753,2043,424
Expenses
1,1581,2181,2971,2531,0541,3841,5512,2222,4322,640
Operating Profit
119125144219173381423753772784
Other Income
67496443283547914177
Interest
19242133293332514130
Depreciation
77869199888786134150146
Profit before tax
89649713184296352659623684
Net Profit
54376310357219263486462517
EPS in Rs
11.217.7012.8120.8211.558.649.8218.1117.1819.24
Dividend Payout %
0%0%0%0%0%0%0%0%0%–

Compounded Profit Growth

10 Years:%
5 Years:37%
3 Years:32%
TTM:32%

Compounded Sales Growth

10 Years:%
5 Years:17%
3 Years:22%
TTM:33%

Return on Equity

10 Years:%
5 Years:14%
3 Years:15%
Last Year:15%

Stock Price CAGR

10 Years:%
5 Years:%
3 Years:38%
1 Year:14%

Balance Sheet

Standalone figures in ₹ crores

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
48484949505154545454
Reserves
1,0701,1411,2301,3411,4341,6892,4352,9833,4443,741
Borrowings
21520116851228308288424337256
Other Liabilities
3033183105172913144025236061,004
Total Liabilities
1,6371,7091,7581,9582,0022,3613,1793,9844,4415,054
Fixed Assets
9661,1628699298518278101,6451,8612,453
Gross Block
1,113.761,400.831,198.401,350.141,353.681,409.621,472.482,491.102,823.29–
Accumulated Depreciation
148.24239.32329.19421.27502.27582.67662.59846.56962.51–
CWIP
87534675280458304
Investments
210356500626734765362366367
Other Assets
6425405285255217941,5291,6981,7571,930
Total Assets
1,6371,7091,7581,9582,0022,3613,1793,9844,4415,054

Cash Flows

Standalone Figures in ₹ Crores / Yearly

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity
124–152193201235431559528
Cash from Investing Activity
-112–-104-45-250-313-257-519-638
Cash from Financing Activity
-6–-49-56-3798404-379-94
Net Cash Flow
6–-192-8620577-339-205

Ratios

Standalone Figures in ₹ Crores / Yearly

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
314142373936322633
Inventory Days
362626373933342924
Days Payable
132124142135134841138481
Cash Conversion Cycle
-66-56-74-61-56-16-48-29-24
Working Capital Days
-31-16-7-11-20-6-27-24-14
ROCE %
–6%8%11%7%17%16%23%20%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters
33.08%33.08%33.07%33.06%33.05%33.04%33.04%33.04%33.03%33.03%33.01%33.01%
FIIs
9.36%9.89%10.58%10.69%11.36%12.10%12.94%12.21%12.48%11.76%11.54%11.41%
DIIs
12.55%12.34%10.79%10.93%11.15%10.25%10.57%11.11%10.51%11.93%12.20%12.97%
Public
45.01%44.67%45.55%45.31%44.45%44.60%43.44%43.64%43.98%43.28%43.19%42.56%

* The classifications might have changed from Sep'2022 onwards.ℹ️

BSE Announcements AI Summary

Direct from BSE filings, auto-summarised

Global Health (Medanta) Files Q4 FY26 Compliance Certificate, Reports Nil Share Dematerialization/Rematerialization

2nd April 2026, 11:27 pm

Global Health Limited to Hold Virtual Investor Meeting with Malaysia's PNB on March 31, 2026

26th March 2026, 9:56 pm

Medanta to Invest ₹550 Cr for New 400-Bed Varanasi Hospital, Approves Medical College Plan

25th March 2026, 9:25 pm

Medanta to Set Up 400-Bed Hospital in Varanasi; Approves Medical College Project

25th March 2026, 9:19 pm

Global Health Approves Grant of 10,000 ESOPs to One Employee

24th March 2026, 7:47 pm

Published by Other Websites

External media mentions & references

US Tariff Threat Hits Indian Pharma Stocks Hard, Index Down 3%

2nd April 2026, 11:10 am

Brokerages Eye 73% Upside: 6 Indian Stocks Rated 'Buy'

29th March 2026, 1:39 pm

Medanta Expands UP Footprint with ₹550 Cr Varanasi Hospital Plan

27th March 2026, 5:39 pm

Infosys Buys US Firms, LIC Faces Tax Demand, Stocks Surge & Dip

27th March 2026, 7:11 am

Medanta to Build ₹550 Crore Hospital in Varanasi, Boosting UP Presence

25th March 2026, 5:49 pm

News Articles

Editorial & research coverage

Indian Earnings Mixed Amid Global Tech Jitters; NSDL Lock-in Expiry Looms
Indian Earnings Mixed Amid Global Tech Jitters; NSDL Lock-in Expiry Looms

5th February 2026, 7:44 am

Global Health's Profit Squeezed by Margins Despite Revenue Rise
Global Health's Profit Squeezed by Margins Despite Revenue Rise

4th February 2026, 4:34 pm

Hospital Earnings Face Q3 Headwinds from Seasonality, Capacity
Hospital Earnings Face Q3 Headwinds from Seasonality, Capacity

13th January 2026, 7:44 pm

BSE Pre-Open: KSB, P&G Hygiene, Medanta Surge on Buyer Demand
BSE Pre-Open: KSB, P&G Hygiene, Medanta Surge on Buyer Demand

7th January 2026, 9:24 am

India's Next Boom! Motilal Oswal Unveils Top Large-Cap Stocks Poised for Massive Wealth Creation by 2026!
India's Next Boom! Motilal Oswal Unveils Top Large-Cap Stocks Poised for Massive Wealth Creation by 2026!

24th December 2025, 11:21 am

Documents

Announcements

Closure of Trading Window

26 Dec - Trading window closed from Jan 1, 2026 until 48 hours after Q3 (Dec 31, 2025) unaudited results.

Announcement under Regulation 30 (LODR)-Credit Rating

16 Dec - CRISIL upgraded Global Health's Rs1,500 crore long-term rating to CRISIL AA/Stable; A1+ reaffirmed (Dec 16, 2025).

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

16 Dec - Listing regulations regarding schedule of analyst meet.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Annual Reports

Financial Year 2025

(from bse)

Financial Year 2024

(from bse)

Financial Year 2023

(from bse)

Credit Ratings

Rating update

16 Dec from crisil

Rating update

16 Oct 2025 from crisil

Rating update

17 Mar 2025 from crisil

Rating update

4 Feb 2025 from crisil

Rating update

21 Jan 2025 from crisil

Rating update

19 Sep 2024 from crisil

Concalls

Nov 2025

TranscriptPPTRecording

Aug 2025

TranscriptPPT

May 2025

TranscriptPPT

May 2025

PPT

Feb 2025

TranscriptPPTRecording

Nov 2024

TranscriptPPT

Aug 2024

TranscriptPPT

May 2024

TranscriptPPT

Feb 2024

TranscriptPPT

Nov 2023

TranscriptPPT

Aug 2023

TranscriptPPT

Aug 2023

PPT

Jun 2023

TranscriptPPT

Feb 2023

TranscriptPPT

Dec 2022

PPT

Stock Analysis

Description

  1. Global Health Limited operates a chain of multi-specialty tertiary care hospitals under the 'Medanta' brand across India, focusing on key medical disciplines and advanced healthcare services.

Key Growth Triggers

  1. Medanta is pursuing strategic growth through new hospital openings (Noida operational, Guwahati under development) and capacity expansions (Mumbai).
  2. Focus remains on increasing patient volumes, improving realizations, and strengthening its presence across North and East India.

Order Book

  1. Currently no data available for Order Book.

Key Red Flags

  1. Currently no data available for Key Red Flags.

Key Dates To Watch

  1. Trading window closure effective Jan 1, 2026, reopening 48 hours after Q3 FY26 results announcement (expected Feb/Mar 2026).

Corporate Announcements

2nd Apr 26
Impact Rating: 3
Global Health Limited (Medanta) has submitted its Q4 FY26 compliance certificate, confirming with its Registrar and Transfer Agent that no shares were dematerialized or rematerialized during the period.
26th Mar 26
Impact Rating: 6
Global Health Limited (Medanta) has scheduled a virtual meeting on March 31, 2026, with Permodalan Nasional Berhad (PNB), a Malaysian institutional investor, to engage on business matters.
25th Mar 26
Impact Rating: 8
Medanta's Board approved a 400-bed hospital in Varanasi requiring a ₹550 crore investment from the company, plus a ₹322 crore medical college project, bolstering its UP presence.
25th Mar 26
Impact Rating: 8
Global Health Limited (Medanta) announced plans to establish a 400-bed multi-specialty hospital in Varanasi with an estimated investment of ₹550 crore. The company's Board also approved a project to set up a medical college costing ₹322 crore.
24th Mar 26
Impact Rating: 7
Global Health's committee approved 10,000 ESOPs for one employee at ₹776 each under the GHL LTIP 2024 Plan, aimed at rewarding performance and retaining talent.